Renaissance Portfolio Moves
Renaissance Technologies Expands Newmont Stake While Adjusting Other Major Holdings
Anonymous
Key Points
1
Newmont Corp. has 68.85% of its stock owned by institutional investors, underscoring heavy institutional participation in the name.
2
In the latest filing, Newmont's stock opened at $93.16, with a market cap around $99.45 billion, a P/E of 11.76, a price/earnings growth (P/E/G) of 1.13, beta of 0.46, debt-to-equity of 0.15, and liquidity ratios showing quick around 2.17 and current around 2.44.
3
Lumentum Holdings has a market cap of about $59.36 billion, a high price-to-earnings ratio of 141.29, beta of 1.48, with its 50-day and 200-day moving averages around $844.69 and $725.88 respectively.
4
Albemarle's CEO J Kent Masters sold 16,393 Albemarle shares on May 15 at an average price of $183.72, totaling about $3.01 million, reducing his stake to 87,519 shares valued around $16.08 million (a 15.78% decrease).
5
Colgate-Palmolive has institutional investors owning 80.41% of its stock; meanwhile JPMorgan Chase & Co. and Piper Sandler raised their price targets to $104 and $96 respectively, with overweight/buy ratings noted by analysts.
Renaissance Technologies, one of Wall Street's most closely watched hedge funds, opened a brand-new position in Newmont Corporation in the first quarter — snapping up 1,671,568 shares worth about $181 million, according to Watchlist News. The move marks a major bet on the world's largest gold miner as institutional investors already control 68.85% of Newmont's stock.
The firm didn't stop there. Renaissance also trimmed its Colgate-Palmolive stake by 17.9% and nearly doubled its position in lithium producer Albemarle — showing the fund is actively reshuffling its large-cap holdings heading into mid-2025.
Renaissance's Big Newmont Bet Signals Gold Confidence
Renaissance bought 1,671,568 Newmont shares in Q1, valued at roughly $181 million. Newmont's stock opened recently at $93.16, giving the company a market cap of about $99.45 billion. The stock carries a low beta of 0.46, meaning it moves less than the broader market. That stability may have attracted the quant-driven fund, according to Watchlist News.
Newmont's financial profile looks solid. Its price-to-earnings ratio sits at 11.76 — a relatively cheap valuation. The debt-to-equity ratio is just 0.15, meaning the company carries very little debt. Its current ratio of 2.44 shows it can easily cover short-term bills. For a fund like Renaissance, those numbers check a lot of boxes.
Albemarle Stake Nearly Doubles as Lithium Interest Grows
Renaissance boosted its Albemarle position by 78.5% in Q1, bringing its total to 730,745 shares worth about $131.2 million. Albemarle is a major lithium producer — a key ingredient in electric vehicle batteries. Renaissance wasn't alone. Other large institutional investors also added to or started new positions in the company during the same period, according to Watchlist News.
But not everyone at Albemarle is buying. CEO J. Kent Masters sold 16,393 shares on May 15 at an average price of $183.72 per share, pulling in about $3.01 million. That sale cut his personal stake by 15.78%, leaving him with 87,519 shares worth roughly $16.08 million. Insider sales don't always signal trouble, but the timing is worth watching.
Colgate Stake Cut as Analysts Raise Price Targets
Renaissance sold 495,600 Colgate-Palmolive shares in Q1, trimming its stake by 17.9%. The fund still holds 2,273,833 shares worth about $193.8 million. Institutional investors as a group own 80.41% of Colgate's stock — a sign the company remains a Wall Street favorite even as Renaissance pulls back, according to Watchlist News.
Wall Street analysts remain upbeat on Colgate. JPMorgan Chase raised its price target to $104, and Piper Sandler bumped its target to $96. Both firms carry bullish ratings on the stock. So while Renaissance is reducing its bet, big banks see more room to run for the consumer goods giant.
Lumentum Buy Adds High-Growth Tech Exposure to Portfolio
Renaissance also picked up 202,838 shares of Lumentum Holdings, valued at roughly $142.5 million. Lumentum is a tech hardware company with a market cap of about $59.36 billion. Its price-to-earnings ratio of 141.29 is extremely high — meaning investors are paying a steep premium for future growth. The stock's 50-day moving average sits at $844.69, well above its 200-day average of $725.88, a sign of recent momentum, according to Watchlist News.
Lumentum carries a beta of 1.48, making it far more volatile than Newmont. That contrast shows Renaissance is playing both sides — pairing a defensive gold miner with a high-risk, high-reward tech name. It's a classic diversification move from a fund known for data-driven precision.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
17
Articles
27
Reach
44
A
AnonymousAuthor
